Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.4K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

628
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
628
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caseload, clinical spectrum and economic burden of infectious diseases in patients discharged from hospitals in Germany.

Infection·2025
Same author

Self-diffusion in two-dimensional quasimagnetized rotating dusty plasmas.

Physical review. E·2019
Same author

Expression profile of pattern recognition receptors in skeletal muscle of SOD1<sup>(G93A)</sup> amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients.

Neuropathology and applied neurobiology·2018
Same author

Direct Determination of Dynamic Properties of Coulomb and Yukawa Classical One-Component Plasmas.

Physical review letters·2018
Same author

[Nontuberculous mycobacterial infections].

Zeitschrift fur Rheumatologie·2017
Same author

[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].

Pneumologie (Stuttgart, Germany)·2017

Related Experiment Video

Updated: Mar 26, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

1.0K

[Immune response to Mycobacterium tuberculosis].

A Nowag1, P Hartmann2,3

  • 1Klinik I für Innere Medizin, Uniklinik Köln, Gleueler Str. 129-131, Gebäude 57, 50937, Köln, Deutschland.

Der Internist
|February 4, 2016
PubMed
Summary

Mycobacterium tuberculosis (MTB) infections involve complex immune responses. Latent tuberculosis (TB) is not dormancy but a dynamic equilibrium, crucial for developing new TB drugs and vaccines.

Keywords:
CytokinesImmunity, adaptiveImmunity, innateLatent tuberculosisTumor necrosis factor alpha

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Related Experiment Videos

Last Updated: Mar 26, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

1.0K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Mycobacterium tuberculosis (MTB) infections trigger intricate immune responses involving both innate and adaptive immunity.
  • Despite over a century since its discovery, the reasons for the immune system's failure to eradicate MTB and its control during latency remain unclear.
  • Understanding tuberculosis (TB) immunology is vital for combating this persistent global health challenge.

Purpose of the Study:

  • To provide an overview of the current advancements in the field of TB immunology.
  • To present a paradigm shift in understanding latent TB, challenging the notion of bacterial dormancy.
  • To highlight the importance of dynamic host-pathogen interactions in latent TB for future therapeutic and vaccine development.

Main Methods:

  • This review synthesizes current research and literature in TB immunology.
  • It focuses on re-evaluating the concept of bacterial stasis during latent infection.
  • The article discusses the dynamic interplay between MTB and the host immune system.

Main Results:

  • The review proposes that latent TB is not a state of dormancy but a dynamic equilibrium.
  • MTB is actively engaged in a complex interplay with the host immune system during the latent phase.
  • This dynamic state challenges traditional views of latent infection.

Conclusions:

  • Understanding the dynamic equilibrium in latent TB is essential for progress in the field.
  • This revised perspective is critical for the development of novel anti-TB drugs.
  • It also paves the way for creating more effective vaccines against tuberculosis.